2014 Fiscal Year Final Research Report
Analysis of expression profile and application to the novel therapeutic target of stem cell replication molecules in lung cancer
| Project/Area Number |
24590701
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Laboratory medicine
|
|---|
| Research Institution | Sapporo Medical University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
WATANABE Naoki 札幌医科大学, 名誉教授 (10158644)
TANAKA Maki 札幌医科大学, 医学部, 助教 (40207139)
KURIBAYASHI Kageaki 札幌医科大学, 医学部, 講師 (50381257)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Keywords | 新規治療標的 / 肺癌 / 抗癌剤耐性 / 再発 / 予測マーカー |
|---|
| Outline of Final Research Achievements |
In this study we aimed to identify novel therapeutic target in lung cancer. For that purpose, we examined the potentiality of SALL4 that expresses especially at early stages of cancer and that its inhibition of the expression leads to growth arrest of the cells. Appropriate level of the inhibition of SALL4 in lung cancer cells resulted in the augmentation of the sensitivity of all investigated anticancer drugs at quite low concentration. Moreover, in lung cancer patients those freshly entried chemotherapy after surgical resection, amounts of SALL4 mRNA expression before chemotherapy was higher in the group showing recurrence after chemotherapy and was further higher in the group showing shorter survival. The data indicate that SALL4 induces drug resistance and could be a novel therapeutic target in lung cancer patients.
|
| Free Research Field |
医歯薬学
|
